AGBAJE MEDICAL LIMITED

Company Registration Number:
NI618360 (Northern Ireland)

Unaudited abridged accounts for the year ended 31 March 2023

Period of accounts

Start date: 01 April 2022

End date: 31 March 2023

AGBAJE MEDICAL LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2023

Balance sheet
Notes

AGBAJE MEDICAL LIMITED

Balance sheet

As at 31 March 2023


Notes

2023

2022


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 2,545 0
Investments: 4 54,286 60,373
Total fixed assets: 56,831 60,373
Current assets
Stocks: 0 0
Debtors:   245,265 244,996
Cash at bank and in hand: 68,256 71,336
Investments:   0 0
Total current assets: 313,521 316,332
Creditors: amounts falling due within one year:   (24,396) (75,848)
Net current assets (liabilities): 289,125 240,484
Total assets less current liabilities: 345,956 300,857
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Total net assets (liabilities): 345,956 300,857
Capital and reserves
Called up share capital: 10 10
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 345,946 300,847
Shareholders funds: 345,956 300,857

The notes form part of these financial statements

AGBAJE MEDICAL LIMITED

Balance sheet statements

For the year ending 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 02 November 2023
and signed on behalf of the board by:

Name: Dr Ishola Agbaje
Status: Director

The notes form part of these financial statements

AGBAJE MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

AGBAJE MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

2. Employees

2023 2022
Average number of employees during the period 3 3

AGBAJE MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

3. Tangible Assets

Total
Cost £
At 01 April 2022 3,000
Additions 2,994
Disposals 0
Revaluations 0
Transfers 0
At 31 March 2023 5,994
Depreciation
At 01 April 2022 3,000
Charge for year 449
On disposals 0
Other adjustments 0
At 31 March 2023 3,449
Net book value
At 31 March 2023 2,545
At 31 March 2022 0

AGBAJE MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

4. Fixed investments

Fixed Asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.